[go: up one dir, main page]

WO2014041440A1 - Honey-based dressing for the treatment of wounds and burns - Google Patents

Honey-based dressing for the treatment of wounds and burns Download PDF

Info

Publication number
WO2014041440A1
WO2014041440A1 PCT/IB2013/050962 IB2013050962W WO2014041440A1 WO 2014041440 A1 WO2014041440 A1 WO 2014041440A1 IB 2013050962 W IB2013050962 W IB 2013050962W WO 2014041440 A1 WO2014041440 A1 WO 2014041440A1
Authority
WO
WIPO (PCT)
Prior art keywords
honey
preferred
based composition
agar
dressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2013/050962
Other languages
French (fr)
Inventor
Carlos A. Alvarado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US14/414,171 priority Critical patent/US20160346335A1/en
Publication of WO2014041440A1 publication Critical patent/WO2014041440A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents

Definitions

  • Angiogenesis This occurs during the proliferative phase of healing when new blood vessels infiltrate the wound and endothelial budding forms capillaries.
  • Adhering dressing the quality of clinging or being closely attached
  • Antimicrobial agent preventing the development or pathogenic action of microbes, helps decrease an infection and allows healing of a wound
  • Antiseptic - A substance that inhibits the growth and development of microorganisms without necessarily killing them. Antiseptics are usually applied to body surfaces.
  • Connective tissue - refers to tissue that protects and supports the body and its organs, and tissues that bind organs together.
  • Debridement the process of removing dead/unhealthy and/or contaminated tissues, foreign bodies, and other debris on the wound, using mechanical, enzymatic or sharp techniques.
  • Disinfectant A chemical or mixture of chemicals used to kill microorganisms, usually applied to inanimate surfaces or objects.
  • Disinfection A physical or chemical means of killing microorganisms, but not necessarily spores.
  • Dressing Any of various materials utilized for covering and protecting a wound.
  • Edema a condition in which the body tissues contain an excessive amount of tissue fluid. It may be local or general swelling
  • Enzymatic activity an organic catalyst produced by living cells (as in digestive juices), but capable of acting independently of the cells producing them. They are capable of inducing chemical changes in other substances without themselves being changed in the process.
  • Epithelialization The process of the formation of new epithelial tissue -the upper layer of the skin-.
  • Eschar - a slough especially one following a cauterization or burn - any agent used to destroy dead tissue and to cause sloughing which produces an eschar (a blackened area) in the treatment of skin disease
  • Excision - Is a surgical procedure requiring incision through the deep dermis (including subcutaneous and deeper tissues) of open wounds, burn eschar, or burn scars.
  • Granulation tissue - Newly formed vascular tissue normally produced in the healing of wounds of soft tissue and ultimately forming the scar; it consists of small, translucent, pink to red, nodular masses of granulations that fill in an open wound bed during the proliferative phase of healing.
  • Inflammation A non-specific host response to invasion of foreign material.
  • Lesion any visible, local abnormality of the tissues of the body, as a wound, sore, rash, or a boil.
  • a lesion may be described as benign, cancerous, gross, occult, or primary
  • Necrosis - localized tissue death that occurs in groups of cells in response to disease or injury may block the flow of blood causing tissue ischemia below the blood clot, or ischemia combined with bacterial action can cause gangrene to set in
  • Purulent - producing or containing pus Ripe honey it is meant honey naturally produced by bees to have water content, in a range known to those skilled in the art, which typically varies from about 14% to about 18% water by weight.
  • Sterilization A process that kills and/or removes all classes of microorganisms and spores.
  • Transparent dressing a dressing that you can see through and visualize the ulcer, but can be occlusive (taped on all four sides)
  • Tissue regeneration - Healing in which lost tissue is replaced by proliferation of cells which reconstruct the normal architecture.
  • Tissue repair - Healing in which lost tissue is replaced by a fibrous scar, which is produced from granulation tissue.
  • Treatment or treating - refers to any means of control of a condition or disorder, including prevention or prophylaxis, cure and relief, or relief of development of the condition or disorder.
  • Ulcer - a circumscribed, craterlike lesion of the skin or mucous membrane resulting from necrosis that accompanies some inflammatory, infectious, or malignant processes.
  • An ulcer may be shallow, involving only the epidermis, or a deep crater going down to the bone
  • Wound dressing - is a material applied to a wound or a diseased part of the body, with or without medication, to protect and assist healing.
  • the invention is directed to a practical active dressing (PAD) honey-based composition, methods of producing the same, and therapeutic applications arising from their utilization.
  • PAD active dressing
  • the term "practical active dressing”, “(PAD)", “dressing” or “wound dressing” refers to three-dimensional structure capable of covering-protecting a wound, performing autolytic debridement (moisture donation) and induction of angiogenesis.
  • PAD therapeutic active dressing
  • dressing refers to three-dimensional structure capable of covering-protecting a wound, performing autolytic debridement (moisture donation) and induction of angiogenesis.
  • any reference to "including humans” placed after references to "warm blooded vertebrates” is intended to clarify that whilst humans are contemplated as recipients of the PAD composition.
  • the ripe honey of bee for use in the (PAD) composition in accordance with the invention are typically prepared whit a preferred viscosity, a preferred pH, a preferred gelling agents, a preferred chemical compounds (for example antimicrobial) and preferred plant extracts.
  • the preparation of a PAD is carried out by the addition of preferred components (group of methyl-phenol and acetic acid constituents), and plant extract (Trigonella foenum-graecum), to the ripe honey, that synergistically enhancing the antimicrobial activity, performing autolytic debridement and the induction of angiogenesis that is beneficial to healing of wounds.
  • preferred components group of methyl-phenol and acetic acid constituents
  • plant extract Trigonella foenum-graecum
  • PAD composition that is non-immunogenic, and, thus, does not induce an adverse host immune response when it is used to wound covering, for performing autolytic debridement (moisture donation) and induction of angiogenesis into a host.
  • this invention provides a process for preparing a practical active dressing (PAD) honey-based composition, and in general, the method for preparing the dressing comprises the steps of obtain ripe honey of bee from proper suppliers that ensure good manufacturing practices.
  • a First Process the operator proceed to Reagent No. 1 preparation by mix Trigonella foenum-graecum seed, demineralized water and vinegar and let stand for three days.
  • a Second Process the operator proceeds to mix the supernatant of reagent No. 1 with ripe honey, Agar Agar and the methil-phenil composition.
  • a Third Process the operator proceeds to boil this composition until the time of starting the ebullition process.
  • a Fourth Process proceed to distribution this mixed composition in and individual box and leave to dry in an environment free of contaminants.
  • Each box should be packaged individually into a vacuum bag (multi-layer synthetic bag) and the bag then is sealed.
  • a Fifth process proceed to Eto Sterilization, which is carried in special chamber, for 24 hours and then air exposed for other 24 hours.
  • PID practical active dressing
  • honey-based composition in cases where native tissue is damaged, in one embodiment, by trauma, or in another embodiment, by burns, or in a further embodiment by vascular skin complications (chronic ulcers).
  • such practical active dressing compositions enables a surgeon to utilize this composition in a diverse range of surgical applications such as burns, wounds, vascular skin complications (chronic ulcers) or extensive injuries presented in theaters of war.
  • another embodiment of this invention is a method of implanting into the vertebrate the PAD composition, prepared as described above comprising the combination of active ingredients of ripe honey, gelling agents (Agar Agar), plant extracts (Trigonella foenum-graecum) and chemical compounds (group of Methyl-phenol and acetic acid) in an amount effective to reduce the pH for the regulation of bacterial growth, to performing Autolytic debridement and induce angiogenesis at the site of administration of the wound dressing.
  • gelling agents Agar Agar
  • plant extracts Trigonella foenum-graecum
  • chemical compounds group of Methyl-phenol and acetic acid
  • the PAD composition produced and used in accordance with this invention upon implantation, can serve for the growth of new endogenous connective tissues in the warm-blooded vertebrate including humans.
  • Connective tissues for the purposes of the present invention include the dermal layer of skin.
  • the PAD composition is used beneficially for wound debridement and induction of angiogenesis from the surrounding connective tissue at a desired site in a warm-blooded vertebrate including humans.
  • this invention provides a method of implanting a dressing of this invention in a subject for immediate wound cover, as show in example # 2 in this discovery.
  • the practical active dressing is implanted in direct contact with the wound bed.
  • the dressing becomes sufficiently adhered to the wound bed, thoroughly integrated at all levels, and will performing wound debridement, induction of angiogenesis and preparation of the wound area for skin autograft, where such is considered additionally required.
  • ripe honey in another embodiment, is contemplated the use of the combination of active ingredients of ripe honey, gelling agents (Agar Agar), plant extracts (Trigonella foenum- graecum) and chemical compounds (group of Methyl-phenol and acetic acid) for the manufacture of other treatment methods or medical applications or products which have not been discussed in the present application, e.g., topical formulations (creams, ointments, gels), transdermal systems, microspheres for drug delivery system, or used for the purpose of improving, developing or enhancing other biotechnological/biological products.
  • gelling agents Agar Agar
  • plant extracts Trigonella foenum- graecum
  • chemical compounds group of Methyl-phenol and acetic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

HONEY-BASED DRESSING FOR THE TREATMENT OF WOUNDS AND BURNS
DESCRIPTION OF THE PREFERRED EMBODIMENTS OF THE INVENTION
DEFINITIONS
In the discussions herein, a number of terms are used. In order to provide a clear and consistent understanding of the specification and claims, the following definitions are provided.
Acute - sharp, severe, having rapid onset, severe symptoms and a short course, not chronic
Angiogenesis - This occurs during the proliferative phase of healing when new blood vessels infiltrate the wound and endothelial budding forms capillaries.
Adhering dressing - the quality of clinging or being closely attached
Antimicrobial agent - preventing the development or pathogenic action of microbes, helps decrease an infection and allows healing of a wound
Antiseptic - A substance that inhibits the growth and development of microorganisms without necessarily killing them. Antiseptics are usually applied to body surfaces.
Bacterial - unicellular microorganisms, lacking chlorophyll, many different kinds of bacteria, germs, creating an infection
Chronic - long, drawn out, applied to a disease that is not acute.
Chronic wound - covered with necrotic (dead) material and surrounded by cellulites, also is described as an infected wound.
Connective tissue - Refers to tissue that protects and supports the body and its organs, and tissues that bind organs together.
Debridement - the process of removing dead/unhealthy and/or contaminated tissues, foreign bodies, and other debris on the wound, using mechanical, enzymatic or sharp techniques.
Disinfectant - A chemical or mixture of chemicals used to kill microorganisms, usually applied to inanimate surfaces or objects.
Disinfection - A physical or chemical means of killing microorganisms, but not necessarily spores.
Dressing - Any of various materials utilized for covering and protecting a wound. Edema - a condition in which the body tissues contain an excessive amount of tissue fluid. It may be local or general swelling
Enzymatic activity - an organic catalyst produced by living cells (as in digestive juices), but capable of acting independently of the cells producing them. They are capable of inducing chemical changes in other substances without themselves being changed in the process.
Epidermis - the outer layer of skin
Epithelialization-The process of the formation of new epithelial tissue -the upper layer of the skin-.
Eschar - a slough, especially one following a cauterization or burn - any agent used to destroy dead tissue and to cause sloughing which produces an eschar (a blackened area) in the treatment of skin disease
Excision - Is a surgical procedure requiring incision through the deep dermis (including subcutaneous and deeper tissues) of open wounds, burn eschar, or burn scars.
Exudates - the tan/grayish material that often forms over an open wound. It consists of proteinaceous material from the wound itself.
Granulation tissue - Newly formed vascular tissue (fragile capillaries) normally produced in the healing of wounds of soft tissue and ultimately forming the scar; it consists of small, translucent, pink to red, nodular masses of granulations that fill in an open wound bed during the proliferative phase of healing.
Infection - The host response to bacterial, viral or similar invasion.
Inflammation - A non-specific host response to invasion of foreign material.
Lesion - any visible, local abnormality of the tissues of the body, as a wound, sore, rash, or a boil. A lesion may be described as benign, cancerous, gross, occult, or primary
Necrosis - localized tissue death that occurs in groups of cells in response to disease or injury, as an example - blood clots may block the flow of blood causing tissue ischemia below the blood clot, or ischemia combined with bacterial action can cause gangrene to set in
Purulent - producing or containing pus Ripe honey - It is meant honey naturally produced by bees to have water content, in a range known to those skilled in the art, which typically varies from about 14% to about 18% water by weight.
Sterilization - A process that kills and/or removes all classes of microorganisms and spores.
Stroma -The supportive framework of an organ usually composed of connective tissue. Superficial - confined to the surface
Transparent dressing - a dressing that you can see through and visualize the ulcer, but can be occlusive (taped on all four sides)
Tissue regeneration - Healing in which lost tissue is replaced by proliferation of cells which reconstruct the normal architecture.
Tissue repair - Healing in which lost tissue is replaced by a fibrous scar, which is produced from granulation tissue.
Treatment or treating - refers to any means of control of a condition or disorder, including prevention or prophylaxis, cure and relief, or relief of development of the condition or disorder.
Ulcer - a circumscribed, craterlike lesion of the skin or mucous membrane resulting from necrosis that accompanies some inflammatory, infectious, or malignant processes. An ulcer may be shallow, involving only the epidermis, or a deep crater going down to the bone
Wound dressing - is a material applied to a wound or a diseased part of the body, with or without medication, to protect and assist healing.
The invention is directed to a practical active dressing (PAD) honey-based composition, methods of producing the same, and therapeutic applications arising from their utilization.
In one embodiment, the term "practical active dressing", "(PAD)", "dressing" or "wound dressing" refers to three-dimensional structure capable of covering-protecting a wound, performing autolytic debridement (moisture donation) and induction of angiogenesis. In another embodiment, any reference to "including humans" placed after references to "warm blooded vertebrates" is intended to clarify that whilst humans are contemplated as recipients of the PAD composition.
In another embodiment the ripe honey of bee for use in the (PAD) composition in accordance with the invention are typically prepared whit a preferred viscosity, a preferred pH, a preferred gelling agents, a preferred chemical compounds (for example antimicrobial) and preferred plant extracts.
In accordance whit one embodiment, the preparation of a PAD is carried out by the addition of preferred components (group of methyl-phenol and acetic acid constituents), and plant extract (Trigonella foenum-graecum), to the ripe honey, that synergistically enhancing the antimicrobial activity, performing autolytic debridement and the induction of angiogenesis that is beneficial to healing of wounds.
The combination of these components results in the preparation of a PAD composition that is non-immunogenic, and, thus, does not induce an adverse host immune response when it is used to wound covering, for performing autolytic debridement (moisture donation) and induction of angiogenesis into a host.
In another embodiment, this invention provides a process for preparing a practical active dressing (PAD) honey-based composition, and in general, the method for preparing the dressing comprises the steps of obtain ripe honey of bee from proper suppliers that ensure good manufacturing practices. In a First Process the operator proceed to Reagent No. 1 preparation by mix Trigonella foenum-graecum seed, demineralized water and vinegar and let stand for three days. Then, in a Second Process the operator proceeds to mix the supernatant of reagent No. 1 with ripe honey, Agar Agar and the methil-phenil composition. After that, in a Third Process the operator proceeds to boil this composition until the time of starting the ebullition process. Next, in a Fourth Process proceed to distribution this mixed composition in and individual box and leave to dry in an environment free of contaminants. Each box should be packaged individually into a vacuum bag (multi-layer synthetic bag) and the bag then is sealed. Afterward, in a Fifth process proceed to Eto Sterilization, which is carried in special chamber, for 24 hours and then air exposed for other 24 hours. In another embodiment, the use of the practical active dressing (PAD) honey-based composition, in cases where native tissue is damaged, in one embodiment, by trauma, or in another embodiment, by burns, or in a further embodiment by vascular skin complications (chronic ulcers).
In accordance with one embodiment, such practical active dressing compositions enables a surgeon to utilize this composition in a diverse range of surgical applications such as burns, wounds, vascular skin complications (chronic ulcers) or extensive injuries presented in theaters of war.
Thus, another embodiment of this invention is a method of implanting into the vertebrate the PAD composition, prepared as described above comprising the combination of active ingredients of ripe honey, gelling agents (Agar Agar), plant extracts (Trigonella foenum-graecum) and chemical compounds (group of Methyl-phenol and acetic acid) in an amount effective to reduce the pH for the regulation of bacterial growth, to performing Autolytic debridement and induce angiogenesis at the site of administration of the wound dressing.
In another embodiment, it is thus the object of the present invention to provide an agent for topical application which has a broad application spectrum and thus may be employed for a plurality of uses, which are as close to natural as possible, and thus is well tolerable without any negative side effects.
In another embodiment, the PAD composition produced and used in accordance with this invention, upon implantation, can serve for the growth of new endogenous connective tissues in the warm-blooded vertebrate including humans.
Connective tissues for the purposes of the present invention include the dermal layer of skin. In accordance with this embodiment, the PAD composition is used beneficially for wound debridement and induction of angiogenesis from the surrounding connective tissue at a desired site in a warm-blooded vertebrate including humans.
In another embodiment, this invention provides a method of implanting a dressing of this invention in a subject for immediate wound cover, as show in example # 2 in this discovery.
In another embodiment, the practical active dressing is implanted in direct contact with the wound bed. In one embodiment, the dressing becomes sufficiently adhered to the wound bed, thoroughly integrated at all levels, and will performing wound debridement, induction of angiogenesis and preparation of the wound area for skin autograft, where such is considered additionally required.
In another embodiment, is contemplated the use of the combination of active ingredients of ripe honey, gelling agents (Agar Agar), plant extracts (Trigonella foenum- graecum) and chemical compounds (group of Methyl-phenol and acetic acid) for the manufacture of other treatment methods or medical applications or products which have not been discussed in the present application, e.g., topical formulations (creams, ointments, gels), transdermal systems, microspheres for drug delivery system, or used for the purpose of improving, developing or enhancing other biotechnological/biological products.
As can be seen from the forgoing description, the concepts of the present disclosure provide numerous advantages
The following examples are presented in order to more fully illustrate the preferred embodiments of the invention. They should in no way be construed, however, as limiting the broad scope of the invention.

Claims

Claims
1 . A practical active dressing (PAD) honey-based composition capable of covering- protecting a wound, performing autolytic debridement (moisture donation) and induces angiogenesis, when is positioned in warm-blooded vertebrate including human subjects. It comprises the combination of active ingredients of ripe honey, gelling agents (Agar Agar), plant extracts (Trigonella foenum- graecum) and chemical compounds (group of Methyl-phenol and acetic acid).
2. The method for preparing a honey-based composition to render it useful for the purposes described herein.
3. The honey-based composition will have a preferred viscosity, a preferred pH, a preferred gelling agent, a preferred chemical compounds (for example antimicrobial) and preferred plant extracts.
4. The honey-based composition of claim 3, in which the preferred gelling agent is Agar Agar, in which the preferred chemical agent by means of pH reduction is Policresulen (Condensation product of metacresolsulfonic acid & methanal), in which the preferred plant extract is from Trigonella foenum-graecum seeds.
5. The honey-based composition of claim 1 , wherein the practical active dressing (PAD) is positioned by surgical means into the warm-blooded vertebrate including human subjects, according of the second example in the present invention.
6. The method of claim 5, wherein said method is used in the treatment of skin loss or damage caused by any type of injury or disease or surgical intervention conducted according to the methods of this invention.
7. A method for inducing the formation of endogenous tissue at a site in need of endogenous tissue growth in a warm blooded vertebrate including human subjects, said method consists of contacting said site with a practical active dressing (PAD) comprising the combination of active ingredients of ripe honey, gelling agents (Agar Agar), plant extracts (Trigonella foenum- graecum) and chemical compounds (group of Methyl-phenol and acetic acid).
8. The use of honey-based composition of claim 1 in the manufacture of other treatment methods or medical applications which have not been discussed in the present application, e.g., topical formulations (creams, ointments, gels), transdermal systems, microspheres for drug delivery system, or used for the purpose of improving, developing or enhancing other biotechnological/biological products.
PCT/IB2013/050962 2012-07-16 2013-02-05 Honey-based dressing for the treatment of wounds and burns Ceased WO2014041440A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/414,171 US20160346335A1 (en) 2012-07-16 2013-02-05 Honey-based dressing for the treatment of wounds and burns

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261672139P 2012-07-16 2012-07-16
US61/672,139 2012-07-16

Publications (1)

Publication Number Publication Date
WO2014041440A1 true WO2014041440A1 (en) 2014-03-20

Family

ID=50277710

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/050962 Ceased WO2014041440A1 (en) 2012-07-16 2013-02-05 Honey-based dressing for the treatment of wounds and burns

Country Status (2)

Country Link
US (1) US20160346335A1 (en)
WO (1) WO2014041440A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012075A (en) * 2015-08-24 2015-11-04 泰州市榕兴医疗用品股份有限公司 Self-adhesive elastic bandage-type alginate dressing
CN105748508A (en) * 2014-12-17 2016-07-13 中国科学院上海药物研究所 Use of policresulen in preparation of drugs for treatment of diseases caused by dengue virus infection
WO2018025060A1 (en) * 2016-08-01 2018-02-08 Alvarado Carlos A Multifunctional-reinforced dressing
WO2018026825A1 (en) * 2016-08-01 2018-02-08 Parvizi Surgical Innovation, Llc Antimicrobial composition and methods of use the same
EP3932204A1 (en) * 2020-06-29 2022-01-05 Mark Edward Fenzl Chemical sterilization of honey

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3009754C (en) 2015-01-29 2020-11-10 Mark R. Wardell Wound healing composition comprising buckwheat honey and methylglyoxal, and methods of use
WO2018226479A1 (en) * 2017-06-06 2018-12-13 Promend Animal Health, Inc. Compositions and methods for treating wounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006894A1 (en) * 1987-03-13 1988-09-22 Ed Geistlich Söhne A.G. Für Chemische Industrie Dressings
CN1480152A (en) * 2002-09-04 2004-03-10 黄振华 Policresulen spraying agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006894A1 (en) * 1987-03-13 1988-09-22 Ed Geistlich Söhne A.G. Für Chemische Industrie Dressings
CN1480152A (en) * 2002-09-04 2004-03-10 黄振华 Policresulen spraying agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GETHIN, G.T. ET AL.: "The impact of Manuka honey dressings on the surface pH of chronic wounds", INTERNATIONAL WOUND JOURNAL., vol. 5, no. 2, May 2008 (2008-05-01), pages 185 - 194 *
MUSTAFA, M.R. ET AL.: "Effects of Trigonella foenum graecum Seed Extract in Combination with Honey on Experimental Wound Healing in Rats", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE AND ADVANCE SCIENCES, vol. 1, no. 1, 2005, pages 29 - 33, Retrieved from the Internet <URL:http://medwelljournals.com/abstract/?doi=ijmmas.2005.29.33> [retrieved on 20131119] *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105748508A (en) * 2014-12-17 2016-07-13 中国科学院上海药物研究所 Use of policresulen in preparation of drugs for treatment of diseases caused by dengue virus infection
CN105748508B (en) * 2014-12-17 2018-08-14 中国科学院上海药物研究所 Purposes of the Policresulen in preparing the drug for treating dengue virus infection associated diseases
CN105012075A (en) * 2015-08-24 2015-11-04 泰州市榕兴医疗用品股份有限公司 Self-adhesive elastic bandage-type alginate dressing
WO2018025060A1 (en) * 2016-08-01 2018-02-08 Alvarado Carlos A Multifunctional-reinforced dressing
WO2018026825A1 (en) * 2016-08-01 2018-02-08 Parvizi Surgical Innovation, Llc Antimicrobial composition and methods of use the same
US20190038569A1 (en) * 2016-08-01 2019-02-07 Carlos A. Alvarado Multifunctional-reinforced dressing
EP3932204A1 (en) * 2020-06-29 2022-01-05 Mark Edward Fenzl Chemical sterilization of honey

Also Published As

Publication number Publication date
US20160346335A1 (en) 2016-12-01

Similar Documents

Publication Publication Date Title
Mirhaj et al. Emerging treatment strategies in wound care
Molan et al. Honey: a biologic wound dressing
WO2014041440A1 (en) Honey-based dressing for the treatment of wounds and burns
Vachhrajani et al. Science of wound healing and dressing materials
KR20190089303A (en) Patch-type wound dressing comprising methylene blue mixture for treating skin wound
Adikwu et al. Application of snail mucin dispersed in detarium gum gel in wound healing
ES2526640T3 (en) Compositions to break and inhibit the reconstitution of the wound biofilm
Borges et al. Enhancing Wound Healing: A Comprehensive Review of Sericin and Chelidonium majus L. as Potential Dressings
Masiero et al. In vitro evaluation of the association of medicinal larvae (Insecta, Diptera, Calliphoridae) and topical agents conventionally used for the treatment of wounds
Fontes et al. Bacterial cellulose/phytotherapic hydrogels as dressings for wound healing
Maruhashi Honey in wound healing
KR101649450B1 (en) Skin wound healing composition
Chelu et al. Aloe vera-based hydrogels for wound healing: properties and therapeutic effects. Gels. 2023; 9: 539
Niezgoda et al. Wound treatment options
RU2416425C1 (en) Anti-decubitus oil
US20220008483A1 (en) Method for obtaining freeze-dried animal skin, freeze-dried animal skin, use thereof and kit
Sarheed et al. Honey products and their potential in wound healing
Kon et al. Natural remedies for the treatment of wounds and wound infection
Lotfi Use of honey as a medicinal product in wound dressing (human and animal studies): a review
US20080102106A1 (en) Wound Healing Composition Comprising Substances From Diptera Larvae
Fortner Review of burn treatment: Early care to current practices
Almaamari Pharmacological effects and pharmaceutical dosage forms development of aloe vera
Sonawane et al. Revolutionizing Burn Care: The Therapeutic Potential of Nile Tilapia Skin
Imran et al. Tualang honey hydrogel in the treatment of split-skin graft donor sites
Pinheiro et al. Comparison of the effects of the CO2 laser and chlorohexidine on the decontamination of infected cutaneous wounds: a histologic study in rats

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13837035

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13837035

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 14414171

Country of ref document: US